Cite
HARVARD Citation
Tanaka, Y. et al. (2015). Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study. Annals of the rheumatic diseases. 74 (2), pp. 389-395. [Online].